Diatrizoate Meglumine Injection

09 January 2009

Products Affected - Description

Diatrizoate meglumine 30% injection
Reno-30, 50 mL vial, 25-pack (NDC 00270-0804-45), Bracco Diagnostics - discontinued
Reno-DIP, 300 mL bottle, 10-pack (NDC 00270-0809-75), Bracco Diagnostics - discontinued
Hypaque-Cysto, 250 mL bottle, 10-pack (NDC 00407-0734-10), GE Healthcare - discontinued

Diatrizoate meglumine 60% injection
Reno-60, 50 mL vial, 10-pack (NDC 00270-0696-49), Bracco Diagnostics - discontinued
Reno-60, 50 mL vial, 25-pack (NDC 00270-0696-50), Bracco Diagnostics - discontinued
Hypaque Meglumine, 50 mL vial, 25-pack (NDC 00407-0746-04), GE Healthcare - discontinued
Hypaque Meglumine, 150 mL bottle, 10-pack (NDC 00407-0749-20), GE Healthcare - discontinued

Reason for the Shortage

• Bracco Diagnostics states that Reno-30, Reno-60, and Reno-DIP have been discontinued due to reduced demand. Cystografin (diatrizoate meglumine 30%) and Cystografin-Dilute (diatrizoate meglumine 18%) remain available.
• GE Healthcare has discontinued Hypaque Meglumine and Hypaque-Cysto for unknown reasons.

Estimated Resupply Dates

• Bracco Diagnostics will continue shipping Reno-30 and Reno-DIP until supplies are depleted. All supplies of Reno-60 have been depleted.
• Bracco Diagnostics has Cystografin available in 100 mL vials (NDC 00270-0149-60) and 300 mL vails (NDC 00270-0149-57) and Cystografin-Dilute in 300 mL vials (NDC 00270-1410-30).

Related Shortages

• Diatrizoate Sodium Injection— No Longer Available
• Edrophonium Injection— Resolved
• Indocyanine Green— Resolved
• Technetium Tc99m Generators

Updated

January 9, 2009; December 5, 2008, University of Utah, Drug Information Service.

Back to Drug Shortage Product Bulletins